
TSE:MFC
This summary was created by AI, based on 28 opinions in the last 12 months.
Manulife Financial (MFC) has garnered mixed reviews from experts, reflecting a range of perspectives on its current standing and future potential. Several analysts highlight the company's strong dividend yield and its robust performance in Asia, suggesting it may be a worthwhile long-term investment, particularly for those seeking income rather than growth. However, concerns regarding earnings fluctuations, market pullbacks, and comparisons with peers like Sun Life Financial indicate that MFC may not be as attractive as other options in the life insurance sector. Many experts recognize the potential for capital appreciation, yet they caution that the stock faces headwinds, especially when considering broader market dynamics and the performance of similar financial institutions. There is a prevailing sentiment that the stock remains a reliable choice, albeit needing careful monitoring amidst potential market corrections.
They have done so much to de-risk their balance sheet and to change the structure of the products that they sell, to be more profitable and less capital markets related. Have built a very strong balance sheet and one of the best capital bases in the industry. Have undertaken some tremendous growth initiatives in Asia as well as the US. Recently made a distribution deal in Asia. Have become very long term in focus and the ROE is improving, which he expects is going to be over 10% going forward. Yield of 2.8%.
Sees 16% in earnings growth over the next couple of years, along with 14% dividend growth. They just combined with an Asian bank to get exclusivity on insurance products. Have stumbled over the last couple of years. EPS has been missing on the core earnings, but they are on track for their 2016 plan. When interest rates go higher, this will be a beneficiary.
Low interest rates creates a real challenge for lifecos. This one has done a good job of transitioning from an insurance company to being more of a wealth management name. Their US wealth management is about 40% of their overall revenue. The real opportunity for them is in Asia and they have positioned themselves well to really compete in that space. He is looking at this name. 2.8% dividend yield.
In lifecos, this would be his favourite. It has the best growth including Asian growth. The catalyst will be that their spreads will widen as rates go up. They are not as sensitive to others as they hedged out in 2008-2009 when rates hit. Starting to give dividend increases which will become more regular. This will give you 8%-10% returns instead of the 5% that we have had.
You think of most financials as benefiting from high interest rates, as they are able to capture a higher spread when rates are rising. People like this one as they have a substantial business in the US. They are also able to grow in Asia. As long as you have lower and declining interest rates, that is a headwind for them.
Canadian banks or Manulife (MFC-T)? Until recently, he thought lifecos showed relatively better valuation than banks. The environment has got to the point now where flight to safety might be tilting a little bit more towards banks. Management has done a superb job since they were in trouble previously and had to cut their dividend. Have changed their product mix so that it is a lot less risky and less exposed to equity markets. Have really built up the wealth side of their business giving them good fees. Expanded in the US through John Hancock and are expanding into Asia quite a bit. A very good long-term hold.